Streetbeat News

Revenues

CP

Canadian Pacific Kansas reported its Q2 2024 adjusted EPS at C$1.05 and sales at C$3.600 billion.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:23 pm

AKR

Acadia Realty Trust (NYSE:AKR) reported Q2 2024 earnings per share of $0.31, meeting analyst expectations. The company achieved quarterly sales of $85.626 million, surpassing the $72.133 million estimate by 18.71%, despite a 2.85% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:21 pm

TEX

Terex (NYSE:TEX) reported Q2 2024 adjusted EPS of $2.16, beating the estimate of $2.06. However, sales of $1.40 billion missed the $1.43 billion estimate, showing a slight decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:20 pm

KRG

Kite Realty Group Trust (NYSE:KRG) reported Q2 2024 earnings per share of $0.53, surpassing the analyst consensus estimate of $0.50 by 6%. The company also reported quarterly sales of $212.434 million, beating the estimate of $207.534 million by 2.36%. This represents a 1.76% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:20 pm

NARI

Inari Medical has raised its full-year 2024 revenue guidance to $594.5 million to $604.5 million, up from the previous range of $592.5 million to $602.5 million. This reflects a growth of approximately 20.5% to 22.5% over 2023. The company expects to achieve sustained operating profitability in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:19 pm

AMD

AMD reported a record revenue of $2.8 billion in its data center segment, marking a 115% year-over-year increase. This growth was driven by strong sales of AMD Instinct GPUs and 4th Gen AMD EPYC CPUs.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:19 pm

INCY

MGNX

MacroGenics, Inc. (NASDAQ:MGNX) announced the achievement of $100 million in milestones from Incyte Corporation related to the development progress of ZYNYZ (retifanlimab-dlwr). This milestone is part of a 2017 collaboration agreement, and MacroGenics remains eligible for additional milestones and royalties. The company expects this milestone to support its cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:19 pm

AXS

Axis Capital Holdings (NYSE:AXS) reported Q2 2024 earnings per share of $2.40, missing the analyst estimate of $2.59. Sales were $1.45 billion, also below the $1.52 billion estimate. Despite the misses, sales increased by 4.79% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:19 pm

HLI

Houlihan Lokey (NYSE:HLI) reported Q1 2025 adjusted EPS of $1.22, beating the estimate of $1.21. Sales were $513.609M, surpassing the $508.673M estimate. EPS increased by 37.08% YoY, and sales grew by 23.51% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:18 pm

VOYA

Voya Financial reported Q2 2024 adjusted EPS of $2.18, beating the estimate of $2.14. Sales were $2.033 billion, surpassing the $1.870 billion estimate and showing an 8.66% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:18 pm